These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 7299115)

  • 1. Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastases in vivo.
    Hanna N; Burton RC
    J Immunol; 1981 Nov; 127(5):1754-8. PubMed ID: 7299115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct evidence for the role of LGL in the inhibition of experimental tumor metastases.
    Barlozzari T; Leonhardt J; Wiltrout RH; Herberman RB; Reynolds CW
    J Immunol; 1985 Apr; 134(4):2783-9. PubMed ID: 3871818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
    Hanna N; Schneider M
    J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of experimental tumor metastasis by selective activation of natural killer cells.
    Hanna N
    Cancer Res; 1982 Apr; 42(4):1337-42. PubMed ID: 6277482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune regulation of metastasis from in vivo derived syngeneic murine melanoma.
    Harning R; Koo GC; Szalay J
    Reg Immunol; 1990; 3(2):97-102. PubMed ID: 1965137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-15 mediates anti-tumor effects after cyclophosphamide injection of tumor-bearing mice and enhances adoptive immunotherapy: the potential role of NK cell subpopulations.
    Evans R; Fuller JA; Christianson G; Krupke DM; Troutt AB
    Cell Immunol; 1997 Jul; 179(1):66-73. PubMed ID: 9259773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of natural killer cell activation: implementation for the control of tumor metastasis.
    Hanna N
    Nat Immun Cell Growth Regul; 1983-1984; 3(1):22-33. PubMed ID: 6235447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
    Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T
    Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
    Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
    J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of natural killer cells in tumor growth and metastasis: C57BL/6 normal and beige mice.
    Talmadge JE; Meyers KM; Prieur DJ; Starkey JR
    J Natl Cancer Inst; 1980 Nov; 65(5):929-35. PubMed ID: 6933263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
    J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanism of natural killer (NK) cell-mediated cytotoxicity (CMC). I. Release of cytotoxic factors specific for NK-sensitive target cells (NKCF) during co-culture of NK effector cells with NK target cells.
    Wright SC; Bonavida B
    J Immunol; 1982 Jul; 129(1):433-9. PubMed ID: 7086139
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice.
    Christianson SW; Greiner DL; Schweitzer IB; Gott B; Beamer GL; Schweitzer PA; Hesselton RM; Shultz LD
    Cell Immunol; 1996 Aug; 171(2):186-99. PubMed ID: 8806787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of leukemia by nonimmune syngeneic spleen cells.
    Cheever MA; Greenberg PD; Fefer A
    J Immunol; 1980 May; 124(5):2137-42. PubMed ID: 7365249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue.
    Donskov F; Basse PH; Hokland M
    Nat Immun; 1996-1997; 15(2-3):134-46. PubMed ID: 9162263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
    Arteaga CL; Hurd SD; Winnier AR; Johnson MD; Fendly BM; Forbes JT
    J Clin Invest; 1993 Dec; 92(6):2569-76. PubMed ID: 7504687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular cytotoxicity and serum inhibition in normal mice following transfer of syngeneic tumor-sensitized cells.
    Fisher B; Wolmark N; Saffer EA
    J Natl Cancer Inst; 1980 Mar; 64(3):579-85. PubMed ID: 6986497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysis of tumor cells by natural killer cells in mice is impeded by platelets.
    Nieswandt B; Hafner M; Echtenacher B; Männel DN
    Cancer Res; 1999 Mar; 59(6):1295-300. PubMed ID: 10096562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality.
    Ellison CA; MacDonald GC; Rector ES; Gartner JG
    J Immunol; 1995 Nov; 155(9):4189-98. PubMed ID: 7594574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice with a targeted mutation in lymphotoxin-alpha exhibit enhanced tumor growth and metastasis: impaired NK cell development and recruitment.
    Ito D; Back TC; Shakhov AN; Wiltrout RH; Nedospasov SA
    J Immunol; 1999 Sep; 163(5):2809-15. PubMed ID: 10453025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.